Altamira Therapeutics Ltd. Par Value Per Share
Altamira Therapeutics Ltd. (CYTOF) had Par Value Per Share of $0.72 per share as of 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes › Per Share
ifrs-full:ParValuePerShare · last filed 2025-04-30
- 2019-05-01: Par Value Per Share 0.40 CHF.
- 2018-12-31: Par Value Per Share 0.02 CHF.
- 2017-12-31: Par Value Per Share 0.40 CHF.
- 2015-12-31: Par Value Per Share 0.40 CHF.
CHF
| Period end | Par Value Per Share |
|---|---|
| 2019-05-01 | 0.40 CHF 6-K/A · filed 2020-09-17 |
| 2018-12-31 | 0.02 CHF 20-F · filed 2019-03-14 |
| 2017-12-31 | 0.40 CHF 20-F · filed 2019-03-14 |
| 2015-12-31 | 0.40 CHF 20-F · filed 2020-04-16 |
CHF/shares
| Period end | Par Value Per Share |
|---|---|
| 2022-02-04 | 25.73 CHF/shares 20-F/A · filed 2024-04-22 |
| 2019-05-01 | 0.40 CHF/shares 6-K/A · filed 2020-09-17 |
| 2018-12-31 | 0.02 CHF/shares 20-F · filed 2019-03-14 |
| 2017-12-31 | 0.40 CHF/shares 20-F · filed 2019-03-14 |
| 2015-12-31 | 0.40 CHF/shares 20-F · filed 2020-04-16 |
USD/shares
| Period end | Par Value Per Share |
|---|---|
| 2024-12-31 | $0.72 20-F · filed 2025-04-30 |
| 2024-06-30 | $0.00 6-K · filed 2024-09-24 |
| 2023-12-31 | $0.00 6-K · filed 2024-09-24 |
| 2023-11-02 | $0.00 6-K · filed 2024-09-24 |